Medication Adherence in Rheumatic Diseases
Study Details
Study Description
Brief Summary
The investigators will pilot test a clinician-led intervention to improve medication adherence in general rheumatology clinic across a spectrum of rheumatic diseases. The study will assess feasibility, acceptability, and fidelity, and explore signal for improved medication adherence.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
N/A |
Study Design
Arms and Interventions
| Arm | Intervention/Treatment |
|---|---|
| Experimental: Intervention Clinicians in this arm will be trained to conduct the adherence intervention in general rheumatology clinic with all follow up patients with a chronic rheumatic disease. Patients seen by these clinicians will contribute to the outcome data collection. |
Behavioral: Clinician-led adherence intervention
The clinician will review real time pharmacy refill data during clinic and use effective communication techniques to discuss adherence with the patient
|
Outcome Measures
Primary Outcome Measures
- Intervention Feasibility [4 weeks]
Percent of providers agreeing to participate
- Intervention Feasibility [4 weeks]
Provider survey based on the Feasibility of Intervention Measure, scores range from 1-5, 5 is most feasible
- Intervention Feasibility [4 weeks]
Percent of visits with EMR documentation of providers reviewing refills
Secondary Outcome Measures
- Acceptability [4 weeks]
Provider survey based on the Acceptability of Intervention Measure, scores range from 1-5, 5 is most acceptable
- Acceptability, as measured by the percentage of patients who report a positive feeling after having an adherence conversation with their providers [4 weeks]
Patient survey will be administered after their provider visit
- Fidelity [4 weeks]
Provider survey about the frequency of conducting the intervention components of reviewing pharmacy refills and using effective communication strategies
- Fidelity [4 weeks]
Frequency of EMR documentation of completing the intervention components of reviewing pharmacy refills and using effective communication strategies
- Change in medication adherence [baseline, 3 months]
90-day medication possession ratio at 3 months after the intervention visit compared to baseline
- Change in medication adherence [baseline, 6 months]
90-day medication possession ratio at 6 months after the intervention visit compared to baseline
Eligibility Criteria
Criteria
Inclusion Criteria:
- all providers at Southpoint Rheumatology All patients with a rheumatic disease diagnosis currently prescribed at least one rheumatic medication will be included in the analysis
Exclusion Criteria:
- new patients, those who are not prescribed any rheumatic disease medications, or do not have available pharmacy refill data
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | Duke University | Durham | North Carolina | United States | 27710 |
Sponsors and Collaborators
- Duke University
Investigators
- Principal Investigator: Kai Sun, MD, MS, Duke Health
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- Pro00108618